Effect of diurnal variations in the QRS complex and T waves on the eligibility for subcutaneous implantable cardioverter-defibrillators

被引:3
|
作者
Miwa, Naoyuki [1 ]
Nagata, Yasutoshi [1 ]
Yamaguchi, Tetsuo [1 ]
Nagase, Masashi [1 ]
Sasaki, Takeshi [2 ]
Nozato, Toshihiro [1 ]
Ashikaga, Takashi [1 ]
Goya, Masahiko [3 ]
Hirao, Kenzo [4 ]
机构
[1] Japanese Red Cross Musashino Hosp, Dept Cardiol, 1-26-1 Kyonancho, Tokyo 1808610, Japan
[2] Disaster Med Ctr, Dept Cardiovasc Med, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Dept Cardiovasc Med, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan
关键词
Brugada syndrome; Defibrillator screening; Holler monitoring; Subcutaneous implantable cardioverter-defibrillator; Sudden cardiac death; BRUGADA SYNDROME; VENTRICULAR-FIBRILLATION; MYOCARDIAL-INFARCTION; ELECTROCARDIOGRAM; ARRHYTHMIAS; PREVALENCE; CANDIDACY; EFFICACY; PATTERN; SAFETY;
D O I
10.1016/j.hrthm.2019.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are an established therapy for preventing sudden cardiac death. However, a considerable number of patients still undergo inappropriate shocks even after conventional preim-plantation electrocardiographic (ECG) screening. OBJECTIVE This study aimed to elucidate the additional effect of diurnal variations in the QRS complex and T waves of 24-hour Hotter screening on S-ICD eligibility. METHODS Patients with transvenous ICDs who did not need pacing were selected for the study. The ECG was recorded by placing the electrodes to simulate the 3 sensing vectors of the S-ICD, with the patient in the standing and supine positions (conventional), during exercise, and during 24-hour Hotter screening. We investigated the additional discrimination of diurnal variations in patients ineligible for S-ICDs as well as characteristics of those patients. RESULTS Of the 86 patients (82% men; mean age 54 +/- 16 years) analyzed by all 3 screenings, 2 (2.3%) and 3 (3.4%) were considered ineligible by conventional and exercise screening, respectively. An additional 21 patients (24.4%) were found ineligible through Holler screening. A multivariate logistic regression analysis demonstrated that Brugada syndrome and an increased QRS duration per millisecond were associated with ineligibility (odds ratio 5.74; 95% confidence interval 1.74-20.2; P = .003 and odds ratio 1.04; 95% confidence interval 1.01-1.07; P = .007, respectively). T-wave oversensing was mostly observed during 0-6 AM, but no significant diurnal variations were observed in the incorrect QRS profiles. CONCLUSION The detection of diurnal variations through Holler monitoring in addition to conventional screening is expected to be useful for determining S-ICD eligibility.
引用
收藏
页码:913 / 920
页数:8
相关论文
共 35 条
  • [31] Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience
    Gasperetti, Alessio
    Schiavone, Marco
    Ziacchi, Matteo
    Vogler, Julia
    Breitenstein, Alexander
    Laredo, Mikael
    Palmisano, Pietro
    Ricciardi, Danilo
    Mitacchione, Gianfranco
    Compagnucci, Paolo
    Bisignani, Antonio
    Angeletti, Andrea
    Casella, Michela
    Picarelli, Francesco
    Fink, Thomas
    Kaiser, Lukas
    Hakmi, Samer
    Calo, Leonardo
    Pignalberi, Carlo
    Santini, Luca
    Lavalle, Carlo
    Pisano, Ennio
    Olivotto, Iacopo
    Tondo, Claudio
    Curnis, Antonio
    Dello Russo, Antonio
    Badenco, Nicolas
    Steffel, Jan
    Love, Charles J.
    Tilz, Roland
    Forleo, Giovanni
    Biffi, Mauro
    HEART RHYTHM, 2021, 18 (12) : 2050 - 2058
  • [32] How likely is the sense-B-noise to affect patients with subcutaneous implantable cardioverter-defibrillators and can we solve that problem in every case?
    Budrejko, Szymon
    Zienciuk-Krajka, Agnieszka
    Oledzki, Szymon
    Danilowicz-Szymanowicz, Ludmila
    Kempa, Maciej
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2023, 46 (12): : 1472 - 1477
  • [33] Children and young adults treated with transvenous and subcutaneous implantable cardioverter-defibrillators: a 22-year single-center experience and new perspectives
    Lewandowski, Michal
    Syska, Pawel
    Kowalik, Ilona
    KARDIOLOGIA POLSKA, 2020, 78 (09) : 869 - 874
  • [34] Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: Rationale and design of the MagnaSafe Registry
    Russo, Robert J.
    AMERICAN HEART JOURNAL, 2013, 165 (03) : 266 - 272
  • [35] Factors determining the choice between subcutaneous or transvenous implantable cardioverter-defibrillators in Poland in comparison with other European countries: a sub-study of the European Heart Rhythm Association prospective survey
    Jedrzejczyk-Patej, Ewa
    Boveda, Serge
    Kalarus, Zbigniew
    Mazurek, Michal
    Goscinska-Bis, Kinga
    Kiliszek, Marek
    Przybylski, Andrzej
    Potpara, Tatjana S.
    Tilz, Roland
    Fumagalli, Stefano
    Dagres, Nikolaos
    Lenarczyk, Radoslaw
    KARDIOLOGIA POLSKA, 2018, 76 (11) : 1507 - 1515